Caxton Associates (New York)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,600
| Closed | -$399K | – | 598 |
|
|
2023
Q1 | $399K | Sell |
2,600
-236,860
| -99% | -$36.4M | 0.06% | 298 |
|
|
2022
Q4 | $43M | Buy |
239,460
+700
| +0.3% | +$126K | 2.87% | 6 |
|
|
2022
Q3 | $28.2M | Buy |
238,760
+2,601
| +1% | +$308K | 3.76% | 2 |
|
|
2022
Q2 | $33.7M | Buy |
236,159
+67,399
| +40% | +$9.63M | 3.28% | 4 |
|
|
2022
Q1 | $29.1M | Buy |
168,760
+104,600
| +163% | +$18M | 2.37% | 6 |
|
|
2021
Q4 | $16.3M | Sell |
64,160
-581
| -0.9% | -$148K | 1.66% | 8 |
|
|
2021
Q3 | $24.9M | Buy |
64,741
+61,320
| +1,792% | +$23.6M | 2.75% | 4 |
|
|
2021
Q2 | $804K | Sell |
3,421
-854
| -20% | -$201K | 0.09% | 81 |
|
|
2021
Q1 | $560K | Buy |
+4,275
| New | +$560K | 0.05% | 122 |
|